EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies for the identification of people with cystic fibrosis responsive to CFTR modulator triple combinations

Pierre-Régis Burgel

Journal of Cystic Fibrosis · 2026-01 · 25 (1) · 3-8

DOI: 10.1016/j.jcf.2025.12.019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cystic Fibrosis, 2026-01. Verfasst von Pierre-Régis Burgel. Beteiligte Einrichtung: Respiratory Medicine and French Cystic Fibrosis National Reference Center, Hôpital Cochin, AP-HP. Centre Université Paris Cité, 27 rue du Faubourg Sa…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Quinolones, Aminophenols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The triple combinations of CFTR modulators, elexacaftor-tezacaftor-ivacaftor and more recently vanzacaftor-tezacaftor-deutivacaftor, have transformed the clinical course of cystic fibrosis (CF). These drug combinations were identified for their ability to restore CFTR function in F508del epithelial cells, and their efficacy has been shown in large randomized clinical trials involving people with CF with at least one F508del variant. Approximately 20 % of pwCF worldwide have no F508del variant however. Recent data show that CFTR modulator triple combinations may be effective in a large subset of pwCF with non-F508del, often rare, CFTR variants. The purpose of this review is to explore the various strategies that may contribute to the identification of all patients with modulator-responsive CFTR variants in order to expand access to these transformative therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorQuinolonesAminophenolsHumansBenzodioxolesDrug CombinationsIndolesChloride Channel AgonistsPyrazolesPyridinesPyrrolidinesQuinolines

Stichwörter der Autor:innen

CFTR modulatorsElexacaftor-tezacaftor-ivacaftorRare CFTR variantsVanzacaftor-tezacaftor-deutivacaftor

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorQuinolonesAminophenolsBenzodioxolesDrug CombinationsIndolesChloride Channel Agoniststezacaftorelexacaftorelexacaftor, ivacaftor, tezacaftor drug combination

Autor:innen und Institutionen

  • Respiratory Medicine and French Cystic Fibrosis National Reference Center, Hôpital Cochin, AP-HP. Centre Université Paris Cité, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; Institut Cochin, Inserm U1016, Unive…

Zitieren

APA

Burgel, P. R. (2026). Strategies for the identification of people with cystic fibrosis responsive to CFTR modulator triple combinations. Journal of Cystic Fibrosis, 25(1), 3-8. https://doi.org/10.1016/j.jcf.2025.12.019

Vancouver

Burgel PR. Strategies for the identification of people with cystic fibrosis responsive to CFTR modulator triple combinations. Journal of Cystic Fibrosis. 2026;25(1):3-8. doi:10.1016/j.jcf.2025.12.019

BibTeX
@article{Burgel2026,
  author = {Burgel, Pierre-Régis},
  title = {Strategies for the identification of people with cystic fibrosis responsive to CFTR modulator triple combinations},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {3--8},
  doi = {10.1016/j.jcf.2025.12.019}
}
Kostenlos starten →